Mostrando ítems 1-2 de 2
Comajoan von Arend, Pau (Fecha de defensa: 2019-12-18)
Recombinant tissue plasminogen activator (rt-PA) is currently the only FDA-approved drug for the treatment of acute ischaemic stroke. However, the application of this therapy is limited to <5-7% of ...
Camprubí Font, Carla (Fecha de defensa: 2019-07-26)
The adherent-invasive Escherichia coli (AIEC) pathotype could play a role in the course of Crohn’s disease. This is characterized by its capacity to adhere to and to invade intestinal epithelial cells ...